Ad-hoc | 13 June 2002 08:16

aap Implantate AG english

aap associated company GEOT gains CE approval for entire product range Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– aap associated company GEOT gains CE approval for entire product range Gesellschaft für Elektro-Osteotherapie (GEOT) mbH, a company in which aap Implantate AG holds a 30% stake, has gained CE approval for its entire product range. Munich-based GEOT has developed a magnetically induced, invasive process to promote and accelerate bone healing known as electro-osteostimulation. aap has until the end of next year to exercise an option to acquire a further 21% of GEOT. The new GEOT process can be combined with all osteosynthesis implants on the market and with the cement-free hip prosthesis developed by aap. The biological effect of electro-osteotherapy consists of making up for the loss of bioelectricity in the injured bone and stimulating the cells to produce the bone tissue needed for the fracture to heal. Electro-osteotherapy is used as a complementary technology, especially in treating pseudarthrosis (joint creation by a nonhealing bone) and femoral head necrosis (death of the head of the femur) and, preventively, in femoral neck fractures. The use of electro-osteotherapy in the cases mentioned reduces the complication rate, ensures the success of treatment and cuts the time needed for treatment. In connection with the introduction of flat-rate payments for hospital treatment these points make the process an economically interesting addition to the range of therapies available in traumatology and orthopedics. CE approval opens up for aap Implantate AG, which has assumed responsibility for sales and marketing of the entire GEOT product range, a highly promising market , the invasive electromedicine segment. In Germany alone, there are roughly 750,000 new cases a year in which the main indications for electro-osteostimulation occur. The company says the market potential for electromagnetic field therapy runs into hundreds of millions of euros. The process has been approved by the German Federal Committee of Doctors and Health Insurers by the medical service of the German health insurers’ associations, so health plans can pay for the treatment. end of ad-hoc-announcement (c)DGAP 13.06.2002 Issuer’s information/explanatory remarks concerning this ad-hoc-announcement: That means GEOT products can be put to use with immediate effect at orthopedic and traumatological centers. aap has built up technology competencies in high- tech metal processing, bone cement, biological implants and electro- osteostimulation that lay a firm and widely-based foundation for successful and highly promising corporate development. ——————————————————————————– WKN: 506660; ISIN: DE0005066609; Index: Listed: Neuer Markt Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 130816 Jun 02